Corporate News
2025
Investor Symposium presentations available online
13 June 2019
Polarean Imaging plc (AIM: POLX), the medical-imaging technology company, with a proprietary drug-device combination product for the magnetic resonance imaging (MRI) market, held an Investor Symposium for investors yesterday. The presentations are now available to view on the Company website:
https://www.polarean-ir.com/content/investors/videos
Enquiries:
| Polarean Imaging plc | www.polarean.com / www.polarean-ir.com |
| Richard Hullihen, Chief Executive Officer | Via Walbrook PR |
| Richard Morgan, Chairman | |
| Walbrook PR | Tel: +44 (0)20 7933 8780 or [email protected] |
| Paul McManus / Anna Dunphy | Mob: +44 (0)7980 541 893 / +44 (0)7879 741 001 |
2024
Investor Symposium presentations available online
13 June 2019
Polarean Imaging plc (AIM: POLX), the medical-imaging technology company, with a proprietary drug-device combination product for the magnetic resonance imaging (MRI) market, held an Investor Symposium for investors yesterday. The presentations are now available to view on the Company website:
https://www.polarean-ir.com/content/investors/videos
Enquiries:
| Polarean Imaging plc | www.polarean.com / www.polarean-ir.com |
| Richard Hullihen, Chief Executive Officer | Via Walbrook PR |
| Richard Morgan, Chairman | |
| Walbrook PR | Tel: +44 (0)20 7933 8780 or [email protected] |
| Paul McManus / Anna Dunphy | Mob: +44 (0)7980 541 893 / +44 (0)7879 741 001 |
2023
Investor Symposium presentations available online
13 June 2019
Polarean Imaging plc (AIM: POLX), the medical-imaging technology company, with a proprietary drug-device combination product for the magnetic resonance imaging (MRI) market, held an Investor Symposium for investors yesterday. The presentations are now available to view on the Company website:
https://www.polarean-ir.com/content/investors/videos
Enquiries:
| Polarean Imaging plc | www.polarean.com / www.polarean-ir.com |
| Richard Hullihen, Chief Executive Officer | Via Walbrook PR |
| Richard Morgan, Chairman | |
| Walbrook PR | Tel: +44 (0)20 7933 8780 or [email protected] |
| Paul McManus / Anna Dunphy | Mob: +44 (0)7980 541 893 / +44 (0)7879 741 001 |
2022
Investor Symposium presentations available online
13 June 2019
Polarean Imaging plc (AIM: POLX), the medical-imaging technology company, with a proprietary drug-device combination product for the magnetic resonance imaging (MRI) market, held an Investor Symposium for investors yesterday. The presentations are now available to view on the Company website:
https://www.polarean-ir.com/content/investors/videos
Enquiries:
| Polarean Imaging plc | www.polarean.com / www.polarean-ir.com |
| Richard Hullihen, Chief Executive Officer | Via Walbrook PR |
| Richard Morgan, Chairman | |
| Walbrook PR | Tel: +44 (0)20 7933 8780 or [email protected] |
| Paul McManus / Anna Dunphy | Mob: +44 (0)7980 541 893 / +44 (0)7879 741 001 |
2021
Investor Symposium presentations available online
13 June 2019
Polarean Imaging plc (AIM: POLX), the medical-imaging technology company, with a proprietary drug-device combination product for the magnetic resonance imaging (MRI) market, held an Investor Symposium for investors yesterday. The presentations are now available to view on the Company website:
https://www.polarean-ir.com/content/investors/videos
Enquiries:
| Polarean Imaging plc | www.polarean.com / www.polarean-ir.com |
| Richard Hullihen, Chief Executive Officer | Via Walbrook PR |
| Richard Morgan, Chairman | |
| Walbrook PR | Tel: +44 (0)20 7933 8780 or [email protected] |
| Paul McManus / Anna Dunphy | Mob: +44 (0)7980 541 893 / +44 (0)7879 741 001 |
2020
Investor Symposium presentations available online
13 June 2019
Polarean Imaging plc (AIM: POLX), the medical-imaging technology company, with a proprietary drug-device combination product for the magnetic resonance imaging (MRI) market, held an Investor Symposium for investors yesterday. The presentations are now available to view on the Company website:
https://www.polarean-ir.com/content/investors/videos
Enquiries:
| Polarean Imaging plc | www.polarean.com / www.polarean-ir.com |
| Richard Hullihen, Chief Executive Officer | Via Walbrook PR |
| Richard Morgan, Chairman | |
| Walbrook PR | Tel: +44 (0)20 7933 8780 or [email protected] |
| Paul McManus / Anna Dunphy | Mob: +44 (0)7980 541 893 / +44 (0)7879 741 001 |
2019
Investor Symposium presentations available online
13 June 2019
Polarean Imaging plc (AIM: POLX), the medical-imaging technology company, with a proprietary drug-device combination product for the magnetic resonance imaging (MRI) market, held an Investor Symposium for investors yesterday. The presentations are now available to view on the Company website:
https://www.polarean-ir.com/content/investors/videos
Enquiries:
| Polarean Imaging plc | www.polarean.com / www.polarean-ir.com |
| Richard Hullihen, Chief Executive Officer | Via Walbrook PR |
| Richard Morgan, Chairman | |
| Walbrook PR | Tel: +44 (0)20 7933 8780 or [email protected] |
| Paul McManus / Anna Dunphy | Mob: +44 (0)7980 541 893 / +44 (0)7879 741 001 |
2018
Investor Symposium presentations available online
13 June 2019
Polarean Imaging plc (AIM: POLX), the medical-imaging technology company, with a proprietary drug-device combination product for the magnetic resonance imaging (MRI) market, held an Investor Symposium for investors yesterday. The presentations are now available to view on the Company website:
https://www.polarean-ir.com/content/investors/videos
Enquiries:
| Polarean Imaging plc | www.polarean.com / www.polarean-ir.com |
| Richard Hullihen, Chief Executive Officer | Via Walbrook PR |
| Richard Morgan, Chairman | |
| Walbrook PR | Tel: +44 (0)20 7933 8780 or [email protected] |
| Paul McManus / Anna Dunphy | Mob: +44 (0)7980 541 893 / +44 (0)7879 741 001 |
Latest News
-
Promotion & Sales Representative Agreement
24 June 2025 -
Result of AGM
09 June 2025 -
FDA expands XENOVIEW® indication to include children from six years of age
02 June 2025
About Us
Latest Annual Report
Investor Alert
Sign up for Email Alerts